Will CORZ hold above $9.93 support amid uncertainty over sustainable earnings momentum?

Will CORZ hold above $9.93 support amid uncertainty over sustainable earnings momentum?
Core Scientific drops 13% today

Core Scientific (CORZ) stock is trading at $11.64, down 13% today and near the session low in a strong bearish move. The price remains below its key moving averages, indicating continued weakness driven by sellers across multiple timeframes.

CORZ price prediction
24H 4.06%
$11.79
48H 2.47%
$11.61
7D -12.97%
$9.86
1M -2.38%
$11.06
3M -31.77%
$7.73
6M -34.69%
$7.4
12M -30.19%
$7.91
Current price: $11.33 -2.0500 15.32%
Closed 11/20
Daily range 11.26 Arrow from to Icon 12.99
Weekly range 13.10 Arrow from to Icon 14.98
Loading...

Highlights

  • Core Scientific reported third-quarter 2026 revenue of $232.87 million and net income of $1.18 billion, mainly from a non-cash gain on warrants.
  • The sharp rise in profit does not indicate operational improvement, injecting uncertainty into the company’s underlying business momentum.
  • Shares of Core Scientific fell 13% to $11.64, with technical indicators showing strong seller pressure and a high probability of further declines toward a $9.93 to $12.48 range in the coming days.

Earnings uncertainty rises as profits driven by non-cash gain

Core Scientific reported third-quarter 2026 revenue of US$232.87 million and net income of US$1.18 billion, with the sharp rise in profit attributed primarily to a non-cash gain on warrants, according to Yahoo Finance. The reliance on this accounting gain, rather than core operational improvement, suggests the result may not reflect sustainable earnings momentum. This earnings composition has heightened uncertainty around the stock’s underlying business trajectory amid ongoing volatility.

Core Scientific asset chart
Core Scientific price dynamics. Source: TradingView.

Downside momentum persists as oversold signals cluster

H1 SMA-20 is at $13.57, H1 SMA-50 at $13.87, and D1 SMA-200 at $19.3, with the price trading below all of these technical levels. The Ichimoku Kijun at $13.21 acts as immediate resistance above the current price. MACD signals a sell, while ADX is neutral — indicating downside momentum without strong trend confirmation. RSI, Stoch RSI, and CCI are all in their respective oversold zones, pointing to a risk of short-lived rebounds but not a reversal. Bull/Bear Power is negative at -1.33, and Awesome Oscillator remains in negative territory, both confirming the dominance of sellers in the current session.

Limited rebound potential as lower range consolidation likely

Over the next two to three trading days, CORZ is expected to trade within a $9.93 to $12.48 volatility band relative to current levels. A short-term consolidation in this lower range is the most probable scenario, given intraday weakness and bearish momentum. If price breaks above immediate resistance at $13.21, a short-lived bounce may materialize, but the probability of a move to the upside is considered very low. Conversely, a drop below $9.93 would likely trigger increased volatility and an extended selloff.

Anton Kharitonov, expert at Traders Union, sees little genuine strength in Core Scientific (CORZ) as both technical and fundamental factors remain weak. The heavy reliance on non-cash gains, rather than operational improvements, adds to the uncertainty. Price action is bearish with the stock trading below H1 SMA-20 at $13.57, H1 SMA-50 at $13.87, and D1 SMA-200 at $19.3. "Until CORZ reclaims key moving averages and shows real earnings momentum, I consider any bounce a selling opportunity rather than a reversal signal."

Earlier, analysts noted that Core Scientific's shift toward data infrastructure for AI drove cautious optimism but was checked by persistent technical and fundamental challenges. The current breakdown below major moving averages and reliance on non-operational earnings underscore increased downside risk, with the $9.93 level now serving as a critical threshold to monitor for potential further volatility.

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.